Original language | English |
---|---|
Pages (from-to) | 1200-1203 |
Number of pages | 4 |
Journal | ChemMedChem |
Volume | 1 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov-2006 |
Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium
Kai Temming*, Marie Lacombe, Roel Q. J. Schaapveld, Laszlo Orfi, Gyorgy Keri, Klaas Poelstra, Grietje Molema, Robbert J. Kok
*Corresponding author for this work
- Groningen University Institute for Drug Exploration (GUIDE)
- Nanomedicine and Drug Targeting
- Nanotechnology and Biophysics in Medicine (NANOBIOMED)
- Biopharmaceuticals, Discovery, Design and Delivery (BDDD)
- Groningen Kidney Center (GKC)
- Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
Research output: Contribution to journal › Article › Academic › peer-review
32
Citations
(Scopus)